Diarylspiro[2.4]heptenes as selective cyclooxygenase-2 inhibitors: A quantitative structure-activity relationship analysis

被引:0
|
作者
Kumar, R [1 ]
Singh, P [1 ]
机构
[1] SK Gov Coll, Dept Chem, Sikar 332001, India
关键词
D O I
暂无
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Both the Fujita-Ban and Hansch quantitative structure-activity relationship (QSAR) analyses, attempted on the data set of 5,6-diarylspiro[2.4]hept-5-enes as the inhibitors of cyclooxygenase-2 (COX-2) have helped to ascertain the role of R- and X-substituents in explaining their observed biological inhibition actions. From both approaches it is concluded that the substitution NH2 instead of Me at R is desirable. In addition, the 3-F and/or 5-Cl having smaller molar refraction values and the 4-Cl and 4-CF3 possessing less hydrophobic-cum-hydrogen acceptor property at X are the preferred substitutions of the aryl ring. For those analogues whose COX-1 inhibition data are available, the selectivity ratio, -logS [S = IC50(COX-2)/IC50(COX-1)], is found to correlate with the electronic and hydrophobic-cum-hydrogen acceptor parameters. From the derived significant correlation, it follows that the higher electron-withdrawing effect produced by 3- and 4-X and the lower hydrophobic-cum-hydrogen accepting effect by 4-X in the aryl ring are highly beneficial.
引用
收藏
页码:1164 / 1168
页数:5
相关论文
共 50 条
  • [41] Quantitative structure-activity relationship studies of a new class of selective aldose reductase inhibitors
    Sharma, R.
    Sahoo, P. K.
    Chaturvedi, S. C.
    INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2008, 47 (06): : 957 - 962
  • [42] Rational Use of Heterogeneous Data in Quantitative Structure-Activity Relationship (QSAR) Modeling of Cyclooxygenase/Lipoxygenase Inhibitors
    Lagunin, Alexey A.
    Geronikaki, Athina
    Eleftheriou, Phaedra
    Pogodin, Pavel V.
    Zakharov, Alexey V.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (02) : 713 - 730
  • [43] Quantitative Structure-Activity Relationship Analysis and Validation of New DNA Gyrase Inhibitors
    Bhuvaneswari, S.
    Aakash, V. Bala
    Ramalakshmi, N.
    Arunkumar, S.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2021, 55 (09) : 886 - 907
  • [44] Exploration of the quantitative Structure-Activity relationships for predicting Cyclooxygenase-2 inhibition bioactivity by Machine learning approaches
    Dibia, Kevin Tochukwu
    Igbokwe, Philomena Kanwulia
    Ezemagu, Godfrey Ifechukwu
    Asadu, Christian Oluchukwu
    RESULTS IN CHEMISTRY, 2022, 4
  • [45] Selective Cyclooxygenase-2 Inhibitors: Design and Synthesis
    Xin Sheng LEI
    Zong Ru GUO
    Ling Bo QU
    Qi Qing ZHU(Institute of Materia Medica. Chinese Academy of Medical SciencesAnd Peking Union Medical College. Beijing 100050)
    Chinese Chemical Letters, 1999, (06) : 469 - 472
  • [46] Renal effects of cyclooxygenase-2 selective inhibitors
    Harris, CJ
    Brater, DC
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2001, 10 (05): : 603 - 610
  • [47] Selective cyclooxygenase-2 inhibitors: Design and synthesis
    Lei, XS
    Guo, ZR
    Qu, LB
    Zhu, QQ
    CHINESE CHEMICAL LETTERS, 1999, 10 (06) : 469 - 472
  • [48] Selective cyclooxygenase-2 inhibitors: hope and facts
    Berenbaum, F
    JOINT BONE SPINE, 2000, 67 (06) : 499 - 501
  • [49] Nephrotoxic potential of selective cyclooxygenase-2 inhibitors
    Sandhu, GK
    Heyneman, CA
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) : 700 - 704
  • [50] Selective cyclooxygenase-2 inhibitors: similarities and differences
    Brune, K
    Hinz, B
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2004, 33 (01) : 1 - 6